Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA procedures under scrutiny in wake of Olympus recall

This article was originally published in Clinica

Executive Summary

Events surrounding a product recall by Olympus America have raised questions about the US FDA's recall process for medical devices. Johns Hopkins Hospital announced last week that infections caused by contaminated bronchoscopes manufactured by the Melville, New York company may have contributed to the deaths by pneumonia of two critically ill patients at the hospital.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT065114

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel